MDD: So a U.S. trial is central to your clinical development program? van Kasteel: It is fair to say the FDA has tremendously raised the bar on troponin testing. Over the past few years there were not a lot of companies that were able to get FDA approval for troponin tests
this is also an interesting comment on how hard FDA approval is to get ..... Obviously due to accuracy / inconsistent test results big advantage to go with m&g to improve test results and also cost depending on what balance you need
- Forums
- ASX - By Stock
- ADO
- Interesting interview re Minicare system
Interesting interview re Minicare system, page-22
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.59M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 2.0¢ | $24.47K | 1.223M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 1498129 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 853965 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 2680848 | 0.020 |
5 | 2141369 | 0.019 |
6 | 1181000 | 0.018 |
3 | 354748 | 0.017 |
4 | 553300 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 853965 | 7 |
0.022 | 505000 | 2 |
0.023 | 563112 | 2 |
0.024 | 370737 | 4 |
0.025 | 439336 | 6 |
Last trade - 11.23am 01/08/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online